DeepX Health has been selected to present at NLS Days 2021, the largest Nordic partnering conference dedicated to the life science industry. Having been selected from hundreds of high-quality applicants, DeepX Health will be given the opportunity to pitch the company for a record-high 95+ global investors as one of 80 Rising Stars - companies that represent the best investment opportunity.
A fully virtual event due to the ongoing pandemic, DeepX Health will present in a video format. We look forward to share more about ourselves and our vision for the future at the conference!
DeepX Health’s DermoSight featured on BBCRead more
DeepX Health’s DermoSight at NHS event on 12 JulyRead more
DeepX Diagnostics Inc.'s DermoSight Receives FDA Clearance for Teledermatology Screening of Suspect Skin Cancer LesionsRead more
DeepX Health’s Skin Cancer Teledermoscopy Services Now in JerseyRead more
New Board Advisor to DeepX HealthRead more
New Head of Product at DeepX HealthRead more
Pharmacy Screening Demonstrates Great Efficiency and Potential for Cost ReductionsRead more
Primary Care Setting Pilot Launched with NHSRead more
DeepX Health to Present at the 8th World Congress of Teledermatology, Imaging and Artificial Intelligence for Skin DiseasesRead more
ScreenCancer Awarded Support for Diagnostic Triage Algorithm-ProjectRead more
DeepX Health to participate at the 7th Annual Dermatology Summit in San FranciscoRead more
DeepX Health to present at Digital Health World Congress in LondonRead more
DeepX Health participate in the DxPx ConferenceRead more
ScreenCancer approved for first round of Horizon 2020 programmeRead more